A three-drug treatment for head and neck cancer (HNC) improves long-term survival so significantly that researchers are calling for the trio to become the standard of care for patients suitable for first-line therapy.
Adding iniparib to gemcitabine and carboplatin significantly increased clinical benefit and survival—but not toxic effects—in women with metastatic triple-negative breast cancer.
An important gene deletion appears to occur in as many as 1 of every 4 cases of glioblastoma—the most common adult brain cancer—scientists have found.
The FDA today recommended to remove the breast-cancer indication from the label of Avastin (bevacizumab) after reviewing the results of four clinical studies.
Long-term follow-up strategies can be defined for patients with early-stage lung cancer, according to a study published in the Journal of Thoracic Oncology (2010 Aug;5(8):1246-50).
Prostate cancer recurrence can be predicted using an ultrasensitive test, according to a study presented at the 2010 Annual Meeting of the American Urological Association.
Colon cancer patients treated after 1995 experience improved overall survival compared to patients treated before 1995, according to a study presented at the 2010 Annual Meeting of the American Society of Clinical Oncology.
Patterns of a novel cancer biomarker in non-small lung carcinomas (NSCLC) may be used to help predict patient outcome, according to a study published in the Journal of Thoracic Oncology (2010;5(5):649-57).